• CalciMedica Announces that FDA Has Strongly Recommended Moving to a Blinded Placebo-controlled Trial with Auxora™ in Patients with Severe COVID-19 Pneumonia

    2 monthes ago - By San Diego Biotechnology

    LA JOLLA, Calif., May 21, 2020 - CalciMedica Inc. , a clinical-stage biotechnology company targeting calcium release-activated calcium channels for the treatment of acute and severe inflammatory......
    Read more ...

     

  • Equillium to Present at Jefferies Virtual Healthcare Conference

    2 monthes ago - By San Diego Biotechnology

    LA JOLLA, Calif., May 21, 2020 - Equillium, Inc. , a clinical-stage biotechnology company leveraging deep understanding of immunobiology to develop novel products to treat severe autoimmune and inflammatory disorders, to......
    Read more ...